BP11104 PTMC, Poly(trimethylene carbonate), Hydroxyl Terminated, IV: 0.5–1.0 dl/g, Mw: 20–49 kDa

PTMC, Poly(trimethylene carbonate), Hydroxyl Terminated, IV: 0.5–1.0 dl/g, Mw: 20–49 kDa Description

PTMC, Poly(trimethylene carbonate), Hydroxyl Terminated, IV: 0.5–1.0 dl/g, Mw: 20–49 kDa is a thermoplastic polymer characterised by its biocompatibility and controlled hydroxyl termination, which facilitates further chemical modifications. The specific intrinsic viscosity range reflects a targeted polymer chain length that affects both processing and degradation behaviour. Offered in granule form, this material is optimised for integration into biomedical devices and advanced polymer research.

PTMC, Poly(trimethylene carbonate), Hydroxyl Terminated, IV: 0.5–1.0 dl/g, Mw: 20–49 kDa Applications

1.         Healthcare
   - Used as a scaffold component in tissue engineering to achieve controlled degradation and enhanced cell adhesion by leveraging its biocompatibility and predictable degradation rate.

2.         Industrial
   - Applied as a binder in formulation processes to obtain consistent drug release profiles by utilising its defined molecular weight distribution and hydroxyl functionality.

3.         Research
   - Employed in polymeric studies to examine chain-end reactions, providing insights into crosslinking behaviour and facilitating the development of advanced biomaterials.

PTMC, Poly(trimethylene carbonate), Hydroxyl Terminated, IV: 0.5–1.0 dl/g, Mw: 20–49 kDa Packing

The product is packaged in moisture-resistant, anti-static containers and sealed within inner bags that include desiccants to maintain product integrity. The packaging safeguards the material against contamination and physical damage during transit. Storage in a cool, dry environment away from direct sunlight is recommended. Custom packaging solutions, including specific labelling and compartmentalisation options, are available upon request.

Additional Information

PTMC, Poly(trimethylene carbonate), is a biodegradable and biocompatible polymer widely studied in the field of biomedical materials. Known for its amorphous nature, it exhibits excellent biocompatibility and biodegradability, and remains in a rubbery state with inherent elasticity at body temperature. Its adjustable degradation profile and processability make it well-suited for applications such as soft tissue engineering, flexible implants, and controlled drug delivery systems. Understanding the relationship between its molecular weight and intrinsic viscosity is essential for tailoring its performance in specific biomedical and industrial contexts.

The presence of hydroxyl end groups provides reactive sites for further chemical modification, covalent conjugation, or chain extension, thereby enhancing its versatility in synthesising block copolymers, cross-linked networks, and functionalised biomaterials. This reactive functionality expands its utility in advanced manufacturing, formulation processes, and the development of customised polymeric systems. Ongoing research continues to refine processing techniques to enhance its performance, reliability, and reproducibility across a growing range of applications.

Regulatory Note: This material is intended for industrial and research applications. It is the customer's responsibility to ensure compliance with all relevant safety and regulatory standards in their intended use.